Hospital
Key West Hma LLC
Key West Hma LLC was paid $4.77M by Medicaid between Jan 2018 and Nov 2024, across 108 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoKEY WEST HMA LLC
KEY WEST, FL 33040
KEY WEST, FL 33040
33aNPI1619922077assigned 05/24/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.77M
24GClaims174,200
24DCodes billed108
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#82 of 163
Median peer was paid$4.77M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,821 | $197K | |
| 2019 | 30,545 | $464K | |
| 2020 | 25,162 | $553K | |
| 2021 | 35,423 | $906K | |
| 2022 | 39,604 | $1.41M | |
| 2023 | 20,986 | $875K | |
| 2024incomplete | 8,659 | $363K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 14,022 | 11,277 | $1.30M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 7,827 | 6,206 | $618K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 12% | 4,217 | 1,156 | $562K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 6.1% | 2,686 | 2,332 | $289K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.9% | 3,366 | 2,545 | $187K |
| 80053 | Comprehensive metabolic panel | 3.9% | 13,274 | 9,440 | $184K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.7% | 875 | 718 | $178K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 1,704 | 1,296 | $159K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 1,341 | 1,212 | $124K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.2% | 2,661 | 2,039 | $106K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.7% | 349 | 137 | $80K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 6,094 | 4,358 | $73K |
96 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.4% | 2,124 | $66K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 261 | $57K |
| 87420 | <1% | 2,000 | $40K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,722 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,224 | $31K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 898 | $30K |
| 87430 | <1% | 3,902 | $29K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,880 | $26K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,051 | $26K |
| 81003 | <1% | 2,993 | $23K | |
| 81001 | <1% | 4,638 | $22K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,836 | $21K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,390 | $21K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,691 | $20K |
| 84703 | <1% | 1,617 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,407 | $18K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,847 | $18K |
| 86900 | <1% | 439 | $18K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,724 | $15K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 442 | $15K |
| 84484 | <1% | 3,453 | $15K | |
| 87400 | <1% | 7,786 | $14K | |
| 85610 | <1% | 3,115 | $13K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,493 | $13K |
| 83690 | <1% | 2,162 | $13K | |
| 85730 | <1% | 2,816 | $13K | |
| 85027 | <1% | 2,486 | $13K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 301 | $12K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,504 | $12K |
| 83735 | <1% | 2,555 | $12K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 292 | $11K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 36 | $11K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 138 | $11K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 414 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 703 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,486 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 842 | $9K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 100 | $9K |
| J2704 | Injection, propofol, 10 mg | <1% | 584 | $8K |
| 80061 | Lipid panel | <1% | 1,498 | $8K |
| 92523 | <1% | 13 | $8K | |
| 87186 | <1% | 1,047 | $7K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,550 | $7K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 148 | $7K |
| 82962 | <1% | 723 | $7K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,046 | $7K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 334 | $7K |
| 83874 | <1% | 223 | $5K | |
| 83880 | <1% | 468 | $5K | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 874 | $5K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 123 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 602 | $5K |
| 96376 | <1% | 695 | $4K | |
| G0378 | Hospital observation service, per hour | <1% | 196 | $4K |
| 87040 | <1% | 616 | $4K | |
| 84702 | <1% | 79 | $4K | |
| 80305 | <1% | 74 | $4K | |
| 87070 | <1% | 199 | $3K | |
| 87077 | <1% | 926 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 61 | $3K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 28 | $3K |
| 82150 | <1% | 305 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 16 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 968 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 703 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 551 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 247 | $2K |
| 83605 | <1% | 337 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 29 | $1K |
| 86901 | <1% | 436 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 349 | $953.83 |
| 73610 | <1% | 24 | $842.22 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 37 | $639.65 |
| 85379 | <1% | 97 | $542.72 | |
| 72110 | <1% | 13 | $471.88 | |
| 86850 | <1% | 55 | $430.36 | |
| 86140 | <1% | 154 | $321.71 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 280 | $305.57 |
| 97161 | <1% | 17 | $276.65 | |
| 84439 | <1% | 421 | $269.28 | |
| 84100 | <1% | 62 | $180.39 | |
| 92653 | <1% | 22 | $161.23 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 301 | $153.46 |
| 73030 | <1% | 16 | $143.11 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 28 | $52.64 |
| 85652 | <1% | 42 | $14.30 | |
| 83655 | <1% | 31 | $12.14 | |
| 87899 | <1% | 13 | $3.54 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 24 | $0.00 |
| 99218 | 0% | 14 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 13 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 34 | $0.00 |
| 82746 | 0% | 16 | $0.00 | |
| 92609 | 0% | 186 | $0.00 | |
| 82607 | 0% | 46 | $0.00 | |
| 82550 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.